| OVERALL SAMPLE (n = 168) |
|||||
| Average age: 70.60 years (range = 47 - 92) |
|||||
| DM |
Yes: 16.7% |
No: 83.3% |
|
|
|
| PAH |
Yes: 53.6% |
No: 46.4% |
|
|
|
| DLP |
Yes: 37% |
No 63% |
|
|
|
| Statins |
Yes: 30.3% |
No: 69.7% |
|
|
|
| Gleason |
G6: 13.6% |
G7: 29.9% |
G8: 26.5% |
G9: 24.5% |
G10: 5.4% |
| T |
T1: 0.9% |
T2: 22.3% |
T3: 55.4% |
T4: 21.4% |
|
| N |
N0: 60.7% |
N1: 29.9% |
N2: 5.6% |
N3: 3.7% |
|
| M |
M0: 49.1% |
M1a: 5% |
M1b: 46% |
|
|
| Risk |
Low: 2.4% |
Medium: 7.1% |
High: 81.5% |
|
|
| 1st Treatment |
RT: 25.5% |
PRL: 14.5% |
HT: 46.1% |
AA: 10.3% |
CT: 2.4% |